This study investigates the therapeutic potential of glycolysis blockage by targeting phosphofructokinase-2/fructose-2, 6-bisphosphatase 3 (PFKFB3) in HNSCC. The gene discussed is PFKFB3; the disease is head and neck squamous cell carcinoma.